chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen legs, thighs, knees, ankles, toes, elbows.; Swollen legs, thighs, knees, ankles, toes, elbows/Swelling joints/finger joints are swollen; Bra got tight; Painful joints/achyness around the kneecap; Low grade fever; Injection site still hurts; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows.), JOINT SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows/Swelling joints/finger joints are swollen), BREAST TENDERNESS (Bra got tight), ARTHRALGIA (Painful joints/achyness around the kneecap) and PYREXIA (Low grade fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Meniere's disease, Pain (Pain syndrome), Hypothyroidism, Sleep problem and Migraine. Concomitant products included LEVOTHYROXINE for Hypothyroidism, TRIAMTERENE for Meniere's disease, SUMATRIPTAN for Migraine, TIZANIDINE for Muscle relaxant, HYDROCODONE for Pain, DIAZEPAM for Sleep problem.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows.), BREAST TENDERNESS (Bra got tight), ARTHRALGIA (Painful joints/achyness around the kneecap), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (Injection site still hurts). 27-Mar-2021, the patient experienced JOINT SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows/Swelling joints/finger joints are swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows.), JOINT SWELLING (Swollen legs, thighs, knees, ankles, toes, elbows/Swelling joints/finger joints are swollen), BREAST TENDERNESS (Bra got tight), ARTHRALGIA (Painful joints/achyness around the kneecap), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (Injection site still hurts) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow-up received and contains no new information On 27-Jul-2021: Follow-up information received on 27-JUL-2021 contains significant information Events swelling of legs and joint swelling added.
Patient developed hives on neck within 45 minutes of vaccination.  Improved without treatment and was released to home.
I started having heart palpitations/irregular heartbeats  on the night of 03/23 until I fell asleep. I had a few heart palpitations on 03/24 during the day and when I laid down for sleep my heart palpitations were non stop all night. It felt like every few minutes my heart would stop, then flutter, them resume normal beating. This was the worst episode This lasted all night until the morning, after I got a little sleep. Since 03/25 the episodes are getting fewer but still linger.
Within hours of vaccine joints swelled and felt warm and arthritic.  Recovered with in 72 hours.  Many foods now taste spoiled or metallic.  Many regularly encountered items now smell rancid.  Has not changed over the months since vaccination.
HPV9, TDAP and MCVP vaccines admin. 10-15 min after patient stood up, then passed out, falling to floor, breaking both top incisors. Immediately seen by dentist for emergency care.
injection site  pain; injection site redness; injection site swelling; injection site Itching; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling and injection site itching. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling and injection site itching were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling and injection site itching to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced severe pain, swelling, redness and itchiness near injection site. The reporter stated that the adverse event may have been reported previously via email by a agent.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unspecified age and gender. On an unspecified date, the unspecified number of patients were administered with improperly stored doses of GARDASIL 9 (lot L013429, exp 21-JUL-2017). No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
pt recv vax 27MAR96 & pt returned to clinic w/c/o arm deltoid area red & hot to touch 2 days later;
Woke up morning following vaccine with swollen eye lid (fluid filled) this occured on/off only in morning upon waking up for 2 months post vaccine.  Also post vaccine left finger (mostly pointer finger) go white and tingly.   Suspected Raynauds per healthcare provider.  No further tested offered, told to watch.  Heart races from time to time sporadically during periods of rest.
Confirmed no additional AE; HCP called to report inadvertent administration of expired PNEUMOVAX 23 to a patient. The product expired on 08/29/2023 and was administered on 09/02/2023. Limited patient demographics provided. Confirmed no additional AE/PQC.; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.    On 02-SEP-2023, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5 mL (lot # U032086, expiration date: 29-AUG-2023) (route of administration, anatomical location not provided) as prophylaxis. It was confirmed that no additional adverse events were reported.  Follow-up information was received from the pharmacist on 25-SEP-2023. The patient's identifiers were updated. The patient was a 46-year-old female. It was reported that the patient "was doing OK" and did not had adverse event. The reporter was not comfortable providing any additional patient information at the time.
6/20/2022  Presented to Hospital after being found down by family in the bathroom with left gaze, mute, and right sided weakness.  Intubated.  CT head showed Left MCA syndrome. Transferred to another Hospital for thrombectomy.  Post thrombectomy with Tici 3 reperfusion.   6/21 Repeat Head CT: stable.   Lasix given x1 dose.   6/22 Repeat Head CT inclusive.  (not sure if bleed vs contrast).  No cuff leak - started on solumedrol  6/23 MRI head: small amount of petechial hemorrhage 6/24:  Still intubated.  Awaiting extubation.
Got the shot and got shingles/suspected vaccination failure; Got Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shot and got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 14-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the shingles shot and in less than a year he/she got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
Within 1st 24 hours after influenza vaccine, patient had pain, warmth & swelling at site of injection (rt deltoid). Patient then developed fever and passed out 20 hours later. Patient taken to hospital. Tests performed did not attribute patient's condition to flu shot. Patient released after about 24 hrs in normal condition.
SICK FOR 10 DAYS AFTER VACCINATION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on AUG-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced sick for 10 days after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick for 10 days after vaccination. This report was non-serious.
I had severe congestion, sneezing, blowing my nose constantly and the headache that goes with it around the eyes. I then contacted my doctors office once I saw my test was positive. They prescribed me Paxlovid.
My initial reaction to the vaccine was very mild (sore arm, fatigue). On day 3, I took a steep walk and felt more out of breath than my normal but otherwise all other symptoms were gone. Vertigo - In the early morning of day 13, I turned over in bed and experienced severe vertigo followed by severe nausea and cold sweats. This lasted approximately one hour. The overwhelming vertigo returned 2x more that day and 3-4x in the past 9 days. Dizziness - After the initial vertigo, I have experienced a constant dizziness or swimminess. I feel like I am rocking on a boat all the time. Ear Pressure - On day 22, I began to feel a pressure in my ears in addition to a bout vertigo and the constant rocking feeling. Previous related issues - I have never experienced vertigo before. I have never experienced constant dizziness before. I have had ear pressure from colds or sinus infections probably 5-6x in my lifetime. I am generally very healthy with no known underlying conditions.
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age an gender. No information regarding the patients' concurrent conditions, medical history and concomitant therapies was reported. On unknown dates, the patients received incorrectly stored doses of ROTATEQ orally (dose not reported) lot # M042172, expiration date: 08-JUN-2018. No adverse effects were reported. The vaccines were stored in 48 degrees Fahrenheit for 36 minutes. The temperature excursion was detected by a 'Digital Data Logger'. There were no previous temperature excursions. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1705USA004464: US-009507513-1705USA009663:
Joint pain, Muscle discomfort Fever (began at 99.2 and rose to 100.6 for the remainder of the day, followed by sustained spike the next day up to 101.2, leveled off and began to reduce the following day first to 100.4 and then to 99.4 until it broke) Arm pain (could not lift arm for several days, felt like joint was locked;  pain, discomfort continued for almost 2 weeks; still feel a little tightness but can finally get my arm raised over my head) Fatigue, tiredness (lasted beyond the fever stage for over a week) Chills (felt like I was in a deep freeze) Site itchiness, odd sensation during week 3  Did not take any Tylenol or any other similar medication either before the injection or afterward, even to this day.
This is a spontaneous report from a contactable consumer (Patient) reported for herself. A 82-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3302, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications included triamterene taken for an unspecified indication, start and stop date were not reported. On an unspecified date the patient had experienced tiredness/extremely tired and headache. Patient received first dose of the PFIZER COVID-19 vaccine last week on Wednesday. Had a reaction of tiredness and headache. Just uncomfortable. Since patient had that should she take the second shot. On 02Mar2021 09:29 patient stated that she had reported her side effects already. Upon follow-up 02Mar2021, it was reported that patient had got the first vaccine (clarified as PFIZER COVID-19 Vaccine) last Wednesday and patient did have the reaction to it. Patient reaction was like, she was extremely tired and headache. Now, since patient had that, It was wise for her to take the second one. Height and Weight: Patient stated, probably about 5 feet 5 inch, patient was not sure as you know when you get older you shrink and body weight. The patient underwent lab tests and procedures which included body height: probably about 5 feet 5 inch on an unspecified date. Patient received the tylenol as treatment for tiredness/extremely tired and headache. The outcome of event was unknown. Follow-up (02Mar2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported that new information included: lab data and clinical information added. No follow-up attempts are possible. No further information is expected.
Still having pain at injection site   First vaccine given 2/27/2021 Second given 3/20/2021
Redness and swelling at the injection site, pain felt during the injection of the needle, elevated temperature (99.8) the follwing day, headache the following two mornings and foggy brain symptom on the third morning.  Treatment at home including ice of the injection site that evening and the following day, and ibuprofen  (200mg) as fever reducer.
I started getting symptoms of persistent coughing and difficulty breathing like a bad cold. On 1/5/2022, I got a rapid and PRC COVID-19 test that showed positive for both and was giving a Z-Pak. My symptoms stayed the same and then eventually went away.
Sick; Initial information was received on 27-Feb-2021 regarding an unsolicited valid non-serious case from a consumer or non-healthcare professional (under reference number: US-SA-SAC20210302000884).  This case involves an adult patient who experienced sick, while the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick (illness) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the event outcome is unknown.  There will be no information on batch number for this case.
We evaluated on 10/20/15 due to continued pain in left shoulder following a Flu Vaccine.  Most often achy pain but increases with movement. Diagnosis Bursitis Left Shoulder. To take ibuprofen/Advil as needed and follow up in 4 weeks at this time.
Started to get sick on Saturday 5/30. Had sore throat and not feeling well. By 6/3 went to urgent care where was diagnosed with pneumonia on both lungs. Was prescribed antibiotic (Z pack) but was not strong enough. Also received cough medicine. On 6/12 went back to doctor and received doxycycline (10 days). Finished medicine yesterday. He is doing better with lingering cough. Had severe fatigue when sick. Received pneumonia vaccine on 2013 with no problems.
infection - left arm; hot at the site - left arm; hard at the site - left arm; very itchy at the site - left arm; rash that got bigger - left arm - started of small 1 inch by 1/2 inch got to be about 4 inches by 2 inches; red marks at site - left arm; This spontaneous case was reported by a consumer and describes the occurrence of INFECTION (infection - left arm), INJECTION SITE WARMTH (hot at the site - left arm), VACCINATION SITE INDURATION (hard at the site - left arm), INJECTION SITE PRURITUS (very itchy at the site - left arm) and INJECTION SITE RASH (rash that got bigger - left arm - started of small 1 inch by 1/2 inch got to be about 4 inches by 2 inches) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFECTION (infection - left arm), INJECTION SITE WARMTH (hot at the site - left arm), VACCINATION SITE INDURATION (hard at the site - left arm), INJECTION SITE PRURITUS (very itchy at the site - left arm), INJECTION SITE RASH (rash that got bigger - left arm - started of small 1 inch by 1/2 inch got to be about 4 inches by 2 inches) and INJECTION SITE ERYTHEMA (red marks at site - left arm). At the time of the report, INFECTION (infection - left arm), INJECTION SITE WARMTH (hot at the site - left arm), VACCINATION SITE INDURATION (hard at the site - left arm), INJECTION SITE PRURITUS (very itchy at the site - left arm), INJECTION SITE RASH (rash that got bigger - left arm - started of small 1 inch by 1/2 inch got to be about 4 inches by 2 inches) and INJECTION SITE ERYTHEMA (red marks at site - left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment medications include Bactrim, Benadryl,Fluocinonide ointment twice daily.  Patient provided consent for safety to Follow-up.
This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 15-month-old male patient who received INFANRIX (batch number 75H53, expiry date 27th September 2016). On 5th August 2014, the patient received the 4th dose of INFANRIX 0.5 ml. On 5th August 2014, less than a day after receiving INFANRIX, the patient experienced injection site rash, injection site urticaria, frequent bowel movements, loose stools and irritability. The patient was treated with Steroid (Not Specified). In 2014, the outcome of the injection site rash and injection site urticaria were recovered/resolved. On an unknown date, the outcome of the frequent bowel movements, loose stools and irritability were recovered/resolved. It was unknown if the reporter considered the injection site rash, injection site urticaria, frequent bowel movements, loose stools and irritability to be related to INFANRIX. Additional details were provided as follows: The mother of the patient called to check the batch number of vaccine. The patient had administration site rash which appeared as hives after receiving the vaccine that spread all over his injection leg, then spread to his other leg, then spread up his body. The only place that didn't get hives rash was on his face. The rash lasted between 4 and half and 5 weeks and which was treated with strong steroid prescription gel given by doctor, who was allergist. The mother reported the patient was bothered by the rash and had signs of irritability. The patient did not receive any other vaccines that date. When the patient received his MMR vaccination at age 2 and half, the doctor tested the patient prior with skin testing and the patient had mild reaction to the allergy testing of the MMR vaccine. The patient was administered the MMR but was treated before with BENADRYL or antihistamines. The vaccine was given in small amounts, taking several hours to fully administer. The allergist also tested the patient recently with skin tests using two different kinds of flu vaccine, FLUZONE and another preservative free flu vaccine, and the patient showed an allergic skin reaction to both of these vaccines. The reporter referred the mother to report the reaction. The mother and allergist were working together to try to pinpoint what the patient was reacting to.
Stomach cramps (severe), vomiting, diarrhea for 6 hours. Tired/Weak for 48 hours.
PATIENT REPORTED A "POX-LIKE" RASH ON ARMS AND LEGS WHICH LASTED FOR 3 DAYS. PATIENT TOOK BENADRYL (ORAL) WHILE EXPERIENCING RASH)
Bloody nose with long clothes removed loud of nose; Headache; Feeling of a concussion; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 14May2021 at 09:30 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD. The patient did not have any allergies to medications, food or other products. Concomitant medication included methylphenidate hydrochloride (CONCERTA) from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 23Apr2021 at 13:15 (at the age of 25-years-old), as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 14:45, the patient experienced bloody nose with long clothes removed loud of nose, headache, feeling of a concussion. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events bloody nose with long clothes removed loud of nose, headache and feeling of a concussion were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Initial unsolicited case received from a nurse via other company Pfizer under the Manufacturer Report Number: 2017183876 on 11 May 2017. This case involves a female patient (age not reported) who was vaccinated with a dose of TETANUS TOXOID (TETANUS) (Batch number, expiry date, dose, dose in series, route and site of administration was not reported) on an unknown date. The patient medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient developed allergy to tetanus. The patient relevant lab tests and corrective treatment was not reported. The outcome of the event was not reported. List of documents held by sender: none.